524 related articles for article (PubMed ID: 38515777)
1. Nanotechnology-based delivery systems to overcome drug resistance in cancer.
Patel H; Li J; Bo L; Mehta R; Ashby CR; Wang S; Cai W; Chen ZS
Med Rev (2021); 2024 Feb; 4(1):5-30. PubMed ID: 38515777
[TBL] [Abstract][Full Text] [Related]
2. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
Yadav P; Ambudkar SV; Rajendra Prasad N
J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
Tekchandani P; Kurmi BD; Paliwal SR
Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines for combating multidrug resistance of cancer.
Zhu YX; Jia HR; Duan QY; Wu FG
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1715. PubMed ID: 33860622
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
6. Novel nanomedicines to overcome cancer multidrug resistance.
Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
[TBL] [Abstract][Full Text] [Related]
7. How can nanomedicines overcome cellular-based anticancer drug resistance?
Sobot D; Mura S; Couvreur P
J Mater Chem B; 2016 Aug; 4(30):5078-5100. PubMed ID: 32263505
[TBL] [Abstract][Full Text] [Related]
8. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
[TBL] [Abstract][Full Text] [Related]
9. Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.
Pillai G; Ceballos-Coronel ML
SAGE Open Med; 2013; 1():2050312113513759. PubMed ID: 26770691
[TBL] [Abstract][Full Text] [Related]
10. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
Xue X; Liang XJ
Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies to overcome taxane resistance in cancer.
Das T; Anand U; Pandey SK; Ashby CR; Assaraf YG; Chen ZS; Dey A
Drug Resist Updat; 2021 Mar; 55():100754. PubMed ID: 33691261
[TBL] [Abstract][Full Text] [Related]
12. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
Bhattacharjee S; Brayden DJ
Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models.
Petrikaite V; D'Avanzo N; Celia C; Fresta M
Drug Resist Updat; 2023 May; 68():100956. PubMed ID: 36958083
[TBL] [Abstract][Full Text] [Related]
14. Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer.
Kalave S; Hegde N; Juvale K
Curr Pharm Des; 2022; 28(38):3140-3157. PubMed ID: 35366765
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine to overcome cancer multidrug resistance.
Yang X; Yi C; Luo N; Gong C
Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
17. Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs.
Miguel RDA; Hirata AS; Jimenez PC; Lopes LB; Costa-Lotufo LV
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015347
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system.
Sun X; Zhao P; Lin J; Chen K; Shen J
Cancer Drug Resist; 2023; 6(2):390-415. PubMed ID: 37457134
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance: Physiological principles and nanomedical solutions.
Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
[TBL] [Abstract][Full Text] [Related]
20. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
Beretta GL; Cavalieri F
Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
